Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs

Blood

Volumn 111, Issue 5, 2008, Pages 2919-2928

  Beilhaek, Andreas ^a,b   Schulz, Stephan ^a,c   Baker, Jeanette ^a   Beilhack, Georg F ^d   Nishimura, Ryosei ^a   Baker, Enosh M ^a   Landan, Gilad ^a   Herman, Edward I ^a   Butcher, Eugene C ^a   Contag, Christopher H ^e   Negrin, Robert S ^a,f  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF ULM   (Germany)

^e STANFORD UNIVERSITY   (United States)

^f Center for Clinical Sciences Research Building   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCKING ANTIBODY; HOMING RECEPTOR; L SELECTIN; MONOCLONAL ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; INTESTINE; LIVER; LYMPHOID TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; T LYMPHOCYTE; ANIMAL; ANTIBODY SPECIFICITY; CELL MOTION; CROSS PRESENTATION; CYTOLOGY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPH NODE; METABOLISM; PATHOLOGY; PEYER PATCH; WHOLE BODY IMAGING;

ANIMALS; CELL MOVEMENT; CROSS-PRIMING; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LYMPH NODES; LYMPHOID TISSUE; MICE; ORGAN SPECIFICITY; PEYER'S PATCHES; RECEPTORS, LYMPHOCYTE HOMING; T-LYMPHOCYTES; TRANSPLANTATION CONDITIONING; WHOLE BODY IMAGING;

EID: 41949129742     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-09-112789     Document Type: Article

References (47)

1. Ferrara JL, Deeg HJ. Graft-versus-host disease. N Engl J Med. 1991;324:667-674.
2. Beilhack A, Schulz S, Baker J, et al. In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. Blood. 2005;106:1113-1122.
3. Miller MJ, Wei SH, Parker I. Cahalan MD. Two-photon imaging of lymphocyte motility and antigen response in intact lymph node. Science. 2002:296:1869-1873.
4. Stoll S, Delon J, Brotz TM, Germain RN. Dynamic imaging of T cell-dendritic cell interactions in lymph nodes. Science. 2002;296:1873-1876.
5. Mempel TR, Henrickson SE, Von Andrian UH. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature. 2004;427:154-159.
6. Panoskaltsis-Mortari A, Price A. Hermanson JR. et al. In vivo imaging of graft-versus-host-disease in mice. Blood. 2004;103:3590-3598.
7. Guy-Grand D, Griscelli C. Vassalli P. The mouse gut T lymphocyte, a novel type of T cell. Nature, origin, and traffic in mice in normal and graft-versus-host conditions. J Exp Med. 1978;148:1661-1677.
8. Campbell DJ, Butcher EC. Rapid acquisition of tissue-specific homing phenotypes by CD4( + ) Tcells activated in cutaneous or mucosal lymphoid tissues. J Exp Med. 2002;195:135-141.
9. Stagg AJ, Kamm MA, Knight SC. Intestinal dendritic cells increase T cell expression of alpha4beta7 integrin. Eur J Immunol. 2002;32:1445-1454.
10. Mora JR, Bono MR, Manjunath N, et al. Selective imprinting of gut-homing T cells by Peyers's patch dendritic cells. Nature. 2003;424:88-93.
11. Johansson-Lindbom B, Svensson M, Wurbel MA, Malissen B, Marquez G, Agace W. Selective generation of gut tropic Tcells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant. J Exp Med. 2003;198:963-969.
12. Stenstad H, EricssonA, Johansson-Lindbom B, et al. Gut-associated lymphoid tissue-primed CD4+ Tcells display CCR9-dependent and-independent homing to the small intestine. Blood. 2006;107:3447-3454.
13. Agace WW. Tissue-tropic effector Tcells: generation and targeting opportunities. Nat Rev Immunol. 2006;6:682-692.
14. Picker LJ, Treer JR, Ferguson-Darnell B, Collins PA, Bergstresser PR, Terstappen LW. Control of lymphocyte recirculation in man. II. Differential regulation of the cutaneous lymphocyte-associated antigen, a tissue-selective homing receptor for skin-homing Tcells. J Immunol. 1993;150:1122-1136.
15. Shlomchik WD, Couzens MS, Tang CB, et al. Prevention of graft versus host disease by inacti- vation of host antigen-presenting cells. Science. 1999;285:412-415.
16. Johansson-Lindbom B, Svensson M, Pabst O, et al. Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing. J Exp Med. 2005;202:1063-1073.
17. Mora JR, Cheng G, Picarella D, Briskin M, Buchanan N, von Andrian UH. Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin-and gut-associated lymphoid tissues. J Exp Med. 2005;201:303-316.
18. IwataM, Hirakiyama A, Eshima Y, Kagechika H, Kato C. Song SY Retinoic acid imprints gut-homing specificity on T cells. Immunity. 2004;21:527-538.
19. Murai M, Yoneyama H, Ezaki T. et al. Peyers's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction. Nat Immunol. 2003;4:154-160.
20. Davenport MP, Grimm MC, Lloyd AR. A homing selection hypothesis for T-cell trafficking. Immunol Today. 2000;21:315-317.
21. DeTogni P Goellner J, Ruddle NH, et al.Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science. 1994;264:703-707.
22. Rennert PD, James D, Mackay F, Browning JL, Hochman PS. Lymph node genesis is induced by signaling through the lymphotoxin beta receptor. Immunity. 1998;9:71-79.
23. Rennert PD, Browning JL, Hochman PS. Selective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization. Int Immunol. 1997;9:1627-1639.
24. Cao YA, Wagers AJ, Beilhack A, et al. Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc Natl Acad Sci U S A. 2004;101:221 -226.
25. Cao YA, Bachmann MH, BeilhackA, et al. Molecular imaging using labeled donor tissues reveals patterns of engraftment, rejection, and survival in transplantation. Transplantation. 2005:80:134-139.
26. El-Asady R, Yuan R, Liu K, et al. TGF-{beta}-dependent CD103 expression by CD8( + ) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease. J Exp Med. 2005;201:1647-1657.
27. Kunkel EJ, Campbell JJ, Haraldsen G, et al. Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J Exp Med. 2000;192:761-768.
28. Svensson M, Marsal J, Ericsson A, et al. CCL25 mediates the localization of recently activated CD8alphabeta(+) lymphocytes to the small-intestinal mucosa. J Clin Invest. 2002;110:1113-1121.
29. Welniak LA, Kuprash DV, Tumanov AV, et al. Peyers patches are not required for acute graft-versus-host disease after myeloablative conditioning and murine allogeneic bone marrow transplantation. Blood. 2006;107:410-412.
30. Lakkis FG, Arakelov A, Konieczny BT, Inoue Y. Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat Med. 2000;6:686-688.
31. Chin R, Zhou P, Alegre ML, Fu YX. Gontounding factors complicate conclusions in aly model. Nat Med. 2001 ;7:1165-1166.
32. Futterer A, Mink K, Luz A, Kosco-Vilbois MH, Pfeffer K. The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity. 1998:9:59-70.
33. Moyron-Quiroz JE, Rangel-Moreno J. Kusser K. et al. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat Med. 2004;10:927-934.
34. Teshima T. Ordemann R, Reddy P, et al. Acute graft-versus-host disease does not require al- loantigen expression on host epithelium. Nat Med. 2002;8:575-581.
35. DeGrendele HC; Estess P, Siegelman MH. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science. 1997;278:672-675.
36. Haddad W, Cooper CJ. Zhang Z, et al. P-selectin and P-selectin glycoprotein ligand 1 are major determinants for Th1 cell recruitment to nonlymphoid effector sites in the intestinal lamina propria. J Exp Med. 2003;198:369-377.
37. Holler E, Kolb HJ, Moller A, et al. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood. 1990;75:1011-1016.
38. Hill GR. Teshima T, Gerbitz A, et al. Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia. J Clin Invest. 1999;104:459-467.
39. Hattori K, Hirano T, Miyajima H, et al. Differential effects of anti-Fas ligand and antitumor necrosis factor alpha antibodies on acute graft-versus-host disease pathologies. Blood. 1998;91:4051 -4055.
40. Piguet PR Grau GE, Allet B, Vassalli P. Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.host disease. J Exp Med. 1987;166:1280-1289.
41. Eyrich M, Burger G, Marquardt K, et al. Sequential expression of adhesion and costimulatory molecules in graft-versus-host disease target organs after murine bone marrow transplantation across minor histocompatibility antigen barriers. Biol Blood Marrow Transplant. 2005;11:371-382.
42. Petrovic A, Alpdogan O, Willis LM, et al. LPAM (alpha 4 beta 7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease. Blood. 2004;103:1542-1547.
43. Clouthier SG, Ferrara JL, Teshima T. Graft-versus-host disease in the absence of the spleen after allogeneic bone marrow transplantation. Transplantation. 2002;73:1679-1681.
44. Murai M, Yoneyama H, Harada A, et al. Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease. J Clin Invest. 1999; 104: 49-57.
45. Wysocki CA, Jiang Q, Panoskaltsis-Mortari A, et al. Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease. Blood. 2005;106:3300- 3307.
46. Chakraverty R, Cote D, Buchli J. et al. An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues. J Exp Med. 2006;203:2021-2031.
47. Lowsky R, Takahashi T. Liu YP, et al. Protective conditioning for acute graft-versus-host disease. N Engl J Med. 2005;353:1321-1331.